ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

December issue of Business & Regulatory Report included (an additional 8 pages of industry news).

December 10, 2004

Senate Gives NCI More Money, Fewer Strings, Orders Grants Paid At Recommended Levels

October 7, 1983

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

May 27, 2005